Indeed, Craft and colleagues found that castration-resistant xenograft sublines of human prostate cancer cells expressed higher levels of the HER-2/neu, receptor tyrosine kinase activated by EGF [92]. This evidence concerns the gene EGF and prostate carcinoma.